Creating a Playbook for Bespoke Gene Therapies

P.J. Brooks, deputy director of the Office for Rare Diseases Research at NCATS, discusses the newly created Bespoke Gene Therapy Consortium, why it is looking beyond the translational science challenges of gene therapies to include manufacturing and regulation, and how it hopes to accelerate the development of gene therapies for rare diseases.